Cascade
About:
Cascade produces novel medications that target nuclear receptors for treating metabolic disorders and inflammation.
Website: http://cascadepharm.com/en/index.aspx
Top Investors: Puhua Capital, CAS Investment Management, Longpan Investment, Huiding Investment, Xinyi Investment Fund Management
Description:
Cascade produces novel medications that target nuclear receptors for treating metabolic disorders and inflammation.
Total Funding Amount:
140M CNY
Headquarters Location:
Shanhai, Shanghai, China
Founded Date:
2017-12-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2023-08-14
IPO Status:
Private
Industries:
© 2025 bioDAO.ai